Myriad Genetics Inc
Diagnostics company · Salt Lake City, Utah, United States · Nasdaq: MYGN
Myriad Genetics Inc is a diagnostics company headquartered in Salt Lake City, Utah, United States. Its shares trade on Nasdaq under the ticker MYGN. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $185,130 in total, most recently in 2000. It has reported private securities offerings to the US SEC, most recently $249,390 sold in a notice filed in 2019.
Myriad Genetics at a glance
What does Myriad Genetics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $185,130 in total (2000).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $249,390 sold (2019).
Frequently asked questions about Myriad Genetics
Where is Myriad Genetics headquartered?
Myriad Genetics Inc is headquartered in Salt Lake City, Utah, United States.
What does Myriad Genetics do?
Myriad Genetics Inc is a diagnostics company. Its SEC industry classification is In Vitro & In Vivo Diagnostic Substances.
Is Myriad Genetics a public company?
Yes. Myriad Genetics Inc trades on Nasdaq under the ticker MYGN.
Similar companies
- Achieve Life Sciences, Inc.Seattle, Washington, United States
- Celldex Therapeutics, Inc.Hampton, New Jersey, United States
- Navidea Biopharmaceuticals, Inc.Dublin, Ohio, United States
- Eyenuk, Inc.Woodland Hills, California, United States
- Lucira Health, Inc.Emeryville, California, United States
- NeuroTrack Technologies, Inc.Redwood City, California, United States
- Biomerica IncIrvine, California, United States
- Meridian Bioscience IncCincinnati, Ohio, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.